Rosuvastatin (Q34880930)

5 August 2017

1 reference

title

Rosuvastatin. (English)

1 reference

5 August 2017

2

Greg L Plosker

1 reference

5 August 2017

Christopher I Carswell

series ordinal

1

1 reference

PubMed ID

12269853

5 August 2017

Blair Jarvis

series ordinal

3

1 reference

5 August 2017

1 January 2002

1 reference

5 August 2017

1 reference

5 August 2017

62

1 reference

5 August 2017

14

1 reference

5 August 2017

2075-85; discussion 2086-7

1 reference

https://scigraph.springernature.com/pub.10.2165/00003495-200262140-00008

5 August 2017

0 references

cites work

Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group

1 reference

12 December 2020

Summary of the second report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II)

1 reference

12 December 2020

The cost of treating dyslipidaemia using National Cholesterol Education Program (NCEP) guidelines

1 reference

12 December 2020

Synthesis and biological activity of methanesulfonamide pyrimidine- and N-methanesulfonyl pyrrole-substituted 3,5-dihydroxy-6-heptenoates, a novel series of HMG-CoA reductase inhibitors

1 reference

12 December 2020

Drug treatment of lipid disorders

1 reference

12 December 2020

The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators

1 reference

12 December 2020

Coronary heart disease: reducing the risk: the scientific background to primary and secondary prevention of coronary heart disease. A worldwide view. International Task force for the Prevention of Coronary Heart disease

1 reference

12 December 2020

Comparative effects of rosuvastatin and atorvastatin across their dose ranges in patients with hypercholesterolemia and without active arterial disease

1 reference

12 December 2020

Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels

1 reference

12 December 2020

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

1 reference

12 December 2020

A perspective on hyperlipidemia: concepts of management in the prevention of coronary artery disease

1 reference

12 December 2020

Rosuvastatin demonstrates greater reduction of low-density lipoprotein cholesterol compared with pravastatin and simvastatin in hypercholesterolaemic patients: a randomized, double-blind study.

1 reference

12 December 2020

A new HMG-CoA reductase inhibitor, rosuvastatin, exerts anti-inflammatory effects on the microvascular endothelium: the role of mevalonic acid

1 reference

12 December 2020

Current, new and future treatments in dyslipidaemia and atherosclerosis

1 reference

12 December 2020

Comparison of effects on low-density lipoprotein cholesterol and high-density lipoprotein cholesterol with rosuvastatin versus atorvastatin in patients with type IIa or IIb hypercholesterolemia

1 reference

12 December 2020

Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)

1 reference

12 December 2020

Preclinical and clinical pharmacology of Rosuvastatin, a new 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor

1 reference

12 December 2020

Prevention of coronary heart disease in clinical practice: recommendations of the Second Joint Task Force of European and other Societies on Coronary Prevention

1 reference

12 December 2020

Effect of rosuvastatin on low-density lipoprotein cholesterol in patients with hypercholesterolemia

1 reference

12 December 2020

10.2165/00003495-200262140-00008

Identifiers

DOI

1 reference

PubMed ID

12269853

Dimensions Publication ID

5 August 2017

0 references

1 reference

PubMed ID

12269853